Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Terapevticheskii Arkhiv|January 1, 1993
[The role of sympathetic reactivity in the development of Raynaud's syndrome]A B Shcherbakov, N G Guseva, Z S MachTerapevticheskii Arkhiv|January 1, 1992
[The use of Capoten in systemic scleroderma]N G Guseva, N V Anikina, A B ShcherbakovTerapevticheskii Arkhiv|January 1, 1985
[Corinfar in the treatment of Raynaud's syndrome in systemic scleroderma (preliminary results)]A B Shcherbakov, N G Guseva, E S MachTerapevticheskii Arkhiv|January 1, 1987
[Treatment of Raynaud's syndrome with calcium entry blockers]A B Shcherbakov, N G Guseva, E S MachRevmatologiia (Moscow, Russia)|April 1, 1990
[The clinical value of determining beta-glucuronidase activity in the cells and blood serum of patients with systemic scleroderma]Z I Volkova, A B Shcherbakov, P Ia Mul'diiarov, et al.Terapevticheskii Arkhiv|January 1, 1988
[Sjögren's syndrome in systemic scleroderma]N G Guseva, M V Simonova, Z Z Kirtava, et al.Terapevticheskii Arkhiv|January 1, 1992
[The clinical significance of detecting the inhibition of topoisomerase I by the sera of patients with systemic scleroderma]A B Shcherbakov, E I Remenson, I D Kirsanova, et al.Terapevticheskii Arkhiv|January 1, 1985
[Correction of microcirculatory disorders in rheumatic diseases]N G Guseva, A S Poltyrev, V I Alekseev, et al.Terapevticheskii Arkhiv|January 1, 1995
[Antiendothelial antibodies in systemic scleroderma and Raynaud's disease]K V Salozhin, A B Shcherbakov, E L Nasonov, et al.Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|February 13, 1999
[Forty years study of systemic scleroderma (data of Institute of Rheumatology, Russian Academy of Medical Sciences)]N G GusevaPageof 6